Reviving minds
with neurocia
ABOUT NEUROCIA
Wearable Neuromodulation Platform
Neurocia is a medtech company developing a proprietary radiofrequency (RF) neuromodulation platform (RF 50–950 MHz) and at‑home medical devices targeting Alzheimer’s disease and other neurodegenerative disorders.
Our first‑generation device, NeuroPod®, combines Radio Frequency (RF) non-invasive neuromodulation with optional photobiomodulation, and gamma‑frequency entrainment in a compact, patient‑friendly form.
Engineering‑driven radiofrequency neuromodulation platform covering 50–950 MHz for targeted brain stimulation.
First proprietary NeuroPod® devices at 915 MHz and 64 MHz, designed for safe, daily, at‑home use in clinical studies.
Building transcranial electromagnetic treatment approaches with multimodal neuromodulation (RF, photobiomodulation, gamma entrainment).
Join us in redefining what’s possible in Alzheimer’s care.
Our first‑generation device, NeuroPod®, combines Radio Frequency (RF) non-invasive neuromodulation with optional photobiomodulation, and gamma‑frequency entrainment in a compact, patient‑friendly form.
Engineering‑driven radiofrequency neuromodulation platform covering 50–950 MHz for targeted brain stimulation.
First proprietary NeuroPod® devices at 915 MHz and 64 MHz, designed for safe, daily, at‑home use in clinical studies.
Building transcranial electromagnetic treatment approaches with multimodal neuromodulation (RF, photobiomodulation, gamma entrainment).
Join us in redefining what’s possible in Alzheimer’s care.
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
What is the NeuroPod®
NeuroPod®: First-generation wearable
Neuromodulation device
A compact cap-like device delivering radiofrequency and multimodal neuromodulation for neurodegenerative diseases such as Alzheimer's or Parkinson's diseases
RF Neuromodulation
Neuropod® integrates radiofrequency (RF) stimulation within 50-950 MHz for targeted brain network modulation
Multimodal Neuromodulation
Optional photobiomodulation and gamma-frequency entrainment can be combined with RF in flexible protocols
At-Home Treatment, Patient-friendly
Neuropod® is a cap lightweight and compact deivce. Designed for daily sessions at home while pursuing routine activities. No discomfort or pain.
Build for Clinical Studies
Proprietary hardware-software stack enabling remote monitoring and integration into neurodegeneration trials.
Patented Technology
Proprietary design for delivering advanced neuromodulation, engineered to target deep brain structures.